cbdMD, Inc. (YCBD) |
| 0.353 -0.002 (-0.56%) 10-14 16:00 |
| Open: | 0.3443 |
| High: | 0.3725 |
| Low: | 0.335 |
| Volume: | 107,920 |
| Market Cap: | 4(M) |
| PE Ratio: | -0.87 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.58 |
| Resistance 1: | 0.48 |
| Pivot price: | 0.42 |
| Support 1: | 0.33 |
| Support 2: | 0.27 |
| 52w High: | 2.56 |
| 52w Low: | 0.33 |
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 01 Oct 2026
Cbdmd Inc (YCBD-A) Stock Price and News - The Globe and Mail
Fri, 25 Sep 2026
What Does cbdMD, Inc.'s (YCBD) Latest Move Mean for Cannabis Stocks Investors? - Kalkine Media
Wed, 02 Sep 2026
cbdMD to Acquire Twinlab Assets; Will Assume $1.75M Debt and Issue 19.9% New Shares - TradingView
Wed, 02 Sep 2026
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness - PR Newswire
Thu, 13 Aug 2026
cbdMD Inc (YCBD) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Thu, 13 Aug 2026
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |